Overview

Effects of Fish Oil on Post Ablation Arrhythmias

Status:
Terminated
Trial end date:
2011-10-01
Target enrollment:
0
Participant gender:
All
Summary
To determine if peri-operative treatment with omega-3 fatty acids is associated with a decrease in the incidence of early recurrences of atrial arrhythmias (within 30 days) and an improvement in probability of long-term maintenance of sinus rhythm after radiofrequency catheter ablation for Atrial Fibrillation.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Michigan
Collaborator:
GlaxoSmithKline
Criteria
Inclusion Criteria:

- Age > 18 years and < 70 years old

- Left atrial size <55 mm

Exclusion Criteria:

- Inability or unwillingness to provide informed consent

- Current therapy with omega-3 fatty acids

- Current therapy with a statin

- Active liver disease

- Significant comorbidity such as end-stage renal disease or cirrhosis

- Valvular prosthesis